Results 21 to 30 of about 131,342 (265)

Thrombotic microangiopathy in children

open access: yesPediatric nephrology (Berlin, West), 2022
The syndrome of thrombotic microangiopathy (TMA) is a clinical-pathological entity characterized by microangiopathic hemolytic anemia, thrombocytopenia, and end organ involvement.
L. Palma   +4 more
semanticscholar   +1 more source

Case report of Salmonella derby septicemia complicated with co-occurrence of disseminated intravascular coagulation and thrombotic microangiopathy

open access: yesBMC Infectious Diseases, 2022
Background Both disseminated intravascular coagulation and thrombotic microangiopathy are complications of sepsis as Salmonella septicemia, respectively.
Yingxin Lin   +6 more
doaj   +1 more source

The thrombotic microangiopathies [PDF]

open access: yesPediatric Nephrology, 2008
The term thrombotic microangiopathy (TMA) encompasses a group of conditions that are defined by, or result from, a similar histopathological lesion. Hemolytic uremic syndrome (HUS), thrombotic thrombocytopenic purpura (TTP), and several other conditions are associated with TMA.
Copelovitch, Lawrence   +1 more
openaire   +2 more sources

A new pathological perspective on thrombotic microangiopathy

open access: yesKidney Research and Clinical Practice, 2022
Thrombotic microangiopathy (TMA) refers to a condition caused by microvascular injury that includes thrombosis, hemolytic anemia, and thrombocytopenia.
Yong-Jin Kim
semanticscholar   +1 more source

THROMBOTIC MICROANGIOPATHY IN THE PATHOGENESIS OF OBSTETRIC COMPLICATIONS

open access: yesАкушерство, гинекология и репродукция, 2016
Thrombotic microangiopathy is one of the most serious thrombotic complications characterized by microvascular thrombosis in various organs and accompanied by thrombocytopenia and hemolytic anemia.
S. V. Akinshina   +3 more
doaj   +1 more source

Infection frequently triggers thrombotic microangiopathy in patients with preexisting risk factors : a single-institution experience [PDF]

open access: yes, 2010
Thrombotic microangiopathies are rare conditions characterized by microangiopathic hemolytic anemia, microthrombi, and multiorgan insult. The disorders, which include hemolytic uremic syndrome and thrombotic thrombocytopenic purpura, are often acute and ...
Catlow, Jamie   +4 more
core   +1 more source

Eculizumab in gemcitabine-induced thrombotic microangiopathy: experience of the French thrombotic microangiopathies reference centre

open access: yesBMC Nephrology, 2021
Background Gemcitabine is a broadly prescribed chemotherapy, the use of which can be limited by renal adverse events, including thrombotic microangiopathy (TMA). Methods This study evaluated the efficacy of eculizumab, a monoclonal antibody targeting the
M. Grall   +14 more
semanticscholar   +1 more source

The use of eculizumab in Capnocytophaga canimorsus associated thrombotic microangiopathy: a case report

open access: yesBMC Infectious Diseases, 2021
Background The use of complement inhibition is well established for complement mediated thrombotic microangiopathy, but its role in secondary forms of thrombotic microangiopathy is debated.
Magnus Holter Bjørkto   +8 more
doaj   +1 more source

Case Report: A Rare Case of Thrombotic Microangiopathy Induced by Remethylation Disorders

open access: yesFrontiers in Medicine, 2022
In this research, we described a very rare case of thrombotic microangiopathy induced by remethylation disorders. A 16-year-old boy presented to the emergency department with 5 months of weakness and fatigue.
Lu Pang   +6 more
doaj   +1 more source

A rare case of renal thrombotic microangiopathy associated with Castleman’s disease [PDF]

open access: yes, 2017
BACKGROUND: Castleman’s disease (CD) is an uncommon, heterogeneous lympho-proliferative disorder leading to high circulating levels of interleukin-6 (IL-6) and vascular endothelial growth factor (VEGF).
Chen, Ying Maggie   +3 more
core   +2 more sources

Home - About - Disclaimer - Privacy